Insider Shareholders with Direct Ownership of Crinetics Pharmaceuticals, Inc. (CRNX)
This section provides a comprehensive overview of the insiders with direct ownership of Crinetics Pharmaceuticals, Inc. (CRNX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Crinetics Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Richard Scott Struthers
President & CEO |
793,819 | 1,599,207 | 410,417 $13.3 Million | 23 |
Apr 02, 2025
Added 16.53%
|
|
Ajay Madan
Chief Development Officer |
129,333 | 13,411 | 176,995 $5.73 Million | 4 |
Mar 01, 2022
Added 4.84%
|
|
Marc Wilson
CFO |
210,385 | 164,698 | 111,092 $3.6 Million | 20 |
Sep 26, 2024
Reduced 18.37%
|
| 34,729 | 0 | 109,246 $3.54 Million | 3 |
Jun 07, 2024
Added 3.02%
|
|
|
Stephen F. Betz
Chief Scientific Officer |
109,767 | 193,457 | 108,588 $3.52 Million | 57 |
Mar 19, 2025
Reduced 0.27%
|
|
Jeff E. Knight
Chief Operating Officer |
157,675 | 74,000 | 87,491 $2.83 Million | 15 |
Mar 19, 2025
Reduced 0.41%
|
|
Dana Pizzuti
Chief Med and Dev Officer |
196,458 | 127,098 | 72,233 $2.34 Million | 27 |
Mar 19, 2025
Reduced 0.18%
|
|
Tobin Schilke
Chief Financial Officer |
52,000 | 0 | 52,000 $1.68 Million | 1 |
Mar 10, 2025
Added 50.0%
|
|
Alan Seth Krasner
Chief Medical Officer |
49,450 | 15,387 | 43,210 $1.4 Million | 8 |
Oct 17, 2023
Reduced 13.94%
|
|
James Hassard
Chief Commercial Officer |
61,000 | 31,741 | 29,259 $947,699 | 7 |
Jul 05, 2024
Reduced 33.89%
|
| 108,600 | 99,200 | 21,936 $710,507 | 18 |
Jun 07, 2024
Added 13.42%
|
|
| 14,400 | 0 | 14,400 $466,416 | 3 |
Jun 07, 2024
Added 19.1%
|
|
| 26,900 | 17,500 | 9,400 $304,466 | 4 |
Jun 07, 2024
Added 26.56%
|
|
| 9,400 | 0 | 9,400 $304,466 | 2 |
Jun 07, 2024
Added 26.56%
|
|
| 9,400 | 0 | 9,400 $304,466 | 2 |
Jun 07, 2024
Added 26.56%
|
|
| 9,400 | 0 | 9,400 $304,466 | 2 |
Jun 07, 2024
Added 26.56%
|